Protective effect of HDL on NADPH oxidase-derived super oxide anion mediates hypoxia-induced cardiomyocyte apoptosis

PLoS One. 2017 Jun 15;12(6):e0179492. doi: 10.1371/journal.pone.0179492. eCollection 2017.

Abstract

Cardiovascular diseases are the leading cause of death of death in Taiwan. Atherosclerosis can lead to serious problems, including heart attack, stroke, or even death. Coronary heart disease (CHD) occurs when plaque builds up in the coronary arteries to cause the ischemic heart disease which will enhance myocardial remodeling and also induce myocardial hypoxia. High density lipoprotein (HDL) has been proposed to have cardio-protective effects. Under hypoxic conditions (1%O2 for 24hr), in H9c2 cells, reactive oxygen species (ROS) is induced which leads to cardiomyocyte apoptosis and cardiac dysfunction. Therefore, the present study described the protective effect of HDL on hypoxia-induced cardiomyocyte damage. We investigated the NADPH oxidase-produced ROS-related signaling pathways and apoptosis in cardiomyocytes under hypoxia conditions. Results showed that the ROS mediated cardiac damage might occur via AT1 and PKC activation. Furthermore, hypoxia downregulated the survival protein (p-AKTser473) and anti-apoptotic protein (BCL2), whereas pro-apoptotic protein, Bax and caspase 3 were upregulated. These detrimental effects by ROS and apoptosis were prevented by HDL pretreatment. Our findings revealed the underlying molecular mechanism by which HDL suppresses the hypoxia-induced cardiomyocyte dysfunction. Further, we elucidated the role of HDL on preventing hypoxia induced cardiomyocyte apoptosis is mediated through the inhibition of NADPH oxidase-derived ROS.

MeSH terms

  • Apoptosis*
  • Caspase 3 / metabolism
  • Cell Hypoxia
  • Cell Line
  • Coronary Disease / metabolism*
  • Coronary Disease / pathology
  • Enzyme Activation / drug effects
  • Humans
  • Lipoproteins, HDL / metabolism*
  • Lipoproteins, HDL / pharmacology
  • Myocytes, Cardiac / metabolism*
  • Myocytes, Cardiac / pathology
  • NADPH Oxidases / metabolism*
  • Protein Kinase C / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Reactive Oxygen Species / metabolism*
  • Receptor, Angiotensin, Type 1 / metabolism
  • bcl-2-Associated X Protein / metabolism

Substances

  • BAX protein, human
  • Lipoproteins, HDL
  • Reactive Oxygen Species
  • Receptor, Angiotensin, Type 1
  • bcl-2-Associated X Protein
  • NADPH Oxidases
  • Proto-Oncogene Proteins c-akt
  • Protein Kinase C
  • CASP3 protein, human
  • Caspase 3

Grants and funding

This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence MOHW106-TDU-B-212-113004. There was no additional external funding received for this study.